Biomerica, Inc.
BMRA
Rank in Stocks
#30483
Biomerica, Inc. is a biomedical technology firm that invents, secures... Biomerica, Inc. is a biomedical technology firm that invents, secures intellectual property for, produces, and globally distributes diagnostic and therapeutic solutions aimed at identifying and addressing a range of medical conditions and diseases. The company's diagnostic testing kits analyze patient samples, such as blood, urine, or stool, to pinpoint various illnesses and health complications. These kits are also capable of quantifying minute concentrations of specific substances like bacteria, hormones, antibodies, antigens, or other compounds present in bodily fluids or waste. Biomerica primarily sells its products for gastrointestinal disorders, food sensitivities, diabetes, and a variety of specialized diagnostic evaluations. Its distribution channels include physicians' clinics, retail pharmacies, and hospital/clinical laboratories. The company is currently developing InFoods, a diagnostic-guided therapy technology for irritable bowel syndrome; products for Helicobacter pylori; and comprehensive diagnostic tools for COVID-19, encompassing their development, testing, validation, and sale. Established in 1971, Biomerica, Inc. maintains its corporate headquarters in Irvine, California.
Share Price
$1.51
Last synced: 2026-11-11
Market Cap
$4.98M
Change (1 day)
2.03%
Change (1 year)
-39.60%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Biomerica, Inc. (BMRA)
Category
Healthcare
EPS for Biomerica, Inc. (BMRA)
EPS as of August 2026 TTM: $-1.63
According to Biomerica, Inc.'s latest financial reports, its current EPS (TTM) is $-1.63. At the end of 2025 the company had an EPS of $-2.16, a decrease compared to its 2024 EPS of $-0.36.
EPS history for Biomerica, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.63 | -24.54% |
| 2025 | $-2.16 | 500.00% |
| 2024 | $-0.36 | -28.00% |
| 2023 | $-0.50 | 38.89% |
| 2022 | $-0.36 | -33.33% |
| 2021 | $-0.54 | 134.78% |
| 2020 | $-0.23 | -11.54% |
| 2019 | $-0.26 | 52.94% |
| 2018 | $-0.17 | 54.55% |
| 2017 | $-0.11 | -45.00% |
| 2016 | $-0.20 | 355.58% |
| 2015 | $-0.04 | 46.33% |
| 2014 | $-0.03 | -137.50% |
| 2013 | $0.08 | 0.00% |
| 2012 | $0.08 | 300.00% |
| 2011 | $0.02 | -140.08% |
| 2010 | $-0.05 | -199.80% |
| 2009 | $0.05 | -82.14% |
| 2008 | $0.28 | 211.11% |
| 2007 | $0.09 | 125.00% |
| 2006 | $0.04 | 33.33% |
| 2005 | $0.03 | -177.12% |
| 2004 | $-0.04 | -7.82% |
| 2003 | $-0.04 | -48.85% |
| 2002 | $-0.08 | -85.27% |
| 2001 | $-0.56 | -34.88% |
| 2000 | $-0.86 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -265.64% |
US
|
|
| $4.09 | -350.92% |
IE
|
|
| $9.45 | -679.75% |
US
|
|
| $2.37 | -245.40% |
US
|
|
| $1.77 | -208.59% |
US
|
Questions about Biomerica, Inc.'s earnings per share (EPS)
What is Biomerica, Inc.'s earnings per share (EPS)?
Biomerica, Inc.'s earnings per share (EPS) over the last twelve months is $-1.63, as of Aug 2026.
What was Biomerica, Inc.'s earnings per share (EPS) in 2025?
In 2025, Biomerica, Inc.'s earnings per share (EPS) was $-2.16, compared with $-0.36 in 2024.
How has Biomerica, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Biomerica, Inc.'s earnings per share (EPS) was highest in 2020 ($-0.23) and lowest in 2025 ($-2.16).
How does Biomerica, Inc.'s earnings per share (EPS) compare with similar companies?
Biomerica, Inc.'s earnings per share (EPS) ($-1.63) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.